FDA Approves Baxter's RIXUBIS For Treatment Of Children With Hemophilia B
September 15, 2014 at 09:01 AM EDT
Baxter International Inc. (NYSE: BAX) today announced that the United States Food and Drug Administration (FDA) has approved RIXUBIS ...